Production (Stage)
Corvus Pharmaceuticals, Inc.
CRVS
$3.49
$0.020.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 99.80% | 91.40% | 29.48% | 27.63% | -35.80% |
| Total Receivables | 291.38% | 242.86% | 342.00% | 258.82% | -87.58% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 105.26% | 25.33% | -24.37% | -11.11% | -6.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.38% | 376.15% | 82.09% | 32.19% | 18.75% |
| Total Current Assets | 99.08% | 94.62% | 29.69% | 27.30% | -35.72% |
|
|
|||||
| Total Current Assets | 99.08% | 94.62% | 29.69% | 27.30% | -35.72% |
| Net Property, Plant & Equipment | 16.88% | -4.12% | -73.03% | -61.21% | -52.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 606.74% | 610.11% | 183.15% | 0.00% | -31.01% |
| Total Assets | 48.28% | 51.27% | 13.23% | 11.23% | -31.12% |
|
|
|||||
| Total Accounts Payable | -18.71% | 69.31% | 33.40% | -42.18% | 14.36% |
| Total Accrued Expenses | -8.14% | -7.76% | -11.26% | -5.78% | -25.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -69.33% | -86.54% | -73.50% | -46.11% | -17.66% |
| Total Finance Division Other Current Liabilities | 2,177.65% | 11,817.96% | 15,306.87% | 5,263.50% | -52.77% |
| Total Other Current Liabilities | 2,177.65% | 11,817.96% | 15,306.87% | 5,263.50% | -52.77% |
| Total Current Liabilities | 38.08% | 415.39% | 535.79% | 69.70% | -18.94% |
|
|
|||||
| Total Current Liabilities | 38.08% | 415.39% | 535.79% | 69.70% | -18.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 50.49% | 429.03% | 506.38% | 55.82% | -27.97% |
|
|
|||||
| Common Stock & APIC | 15.29% | 15.09% | 6.49% | 6.53% | 2.79% |
| Retained Earnings | -12.16% | -18.61% | -17.32% | -7.02% | -7.88% |
| Treasury Stock & Other | 1.65% | -33.20% | 48.86% | 0.95% | -193.78% |
| Total Common Equity | 47.84% | -15.81% | -71.98% | 3.52% | -31.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.84% | -15.81% | -71.98% | 3.52% | -31.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.84% | -15.81% | -71.98% | 3.52% | -31.72% |
|
|
|||||